Aetna Target of Unusually High Options Trading (AET)

Aetna Inc (NYSE:AET) was the recipient of some unusual options trading on Wednesday. Investors acquired 3,507 put options on the stock. This is an increase of 1,487% compared to the average daily volume of 221 put options.

Institutional investors have recently bought and sold shares of the company. FMR LLC grew its position in Aetna by 3.5% during the 2nd quarter. FMR LLC now owns 7,734,487 shares of the company’s stock worth $1,419,279,000 after acquiring an additional 261,463 shares during the last quarter. Northern Trust Corp grew its position in Aetna by 0.8% during the 2nd quarter. Northern Trust Corp now owns 3,803,810 shares of the company’s stock worth $697,999,000 after acquiring an additional 28,520 shares during the last quarter. PointState Capital LP grew its position in Aetna by 111.2% during the 2nd quarter. PointState Capital LP now owns 2,193,062 shares of the company’s stock worth $402,427,000 after acquiring an additional 1,154,818 shares during the last quarter. Summit Trail Advisors LLC grew its position in Aetna by 55,803.4% during the 1st quarter. Summit Trail Advisors LLC now owns 1,616,727 shares of the company’s stock worth $1,617,000 after acquiring an additional 1,613,835 shares during the last quarter. Finally, Abrams Capital Management L.P. grew its position in Aetna by 14.1% during the 2nd quarter. Abrams Capital Management L.P. now owns 1,575,000 shares of the company’s stock worth $289,013,000 after acquiring an additional 195,000 shares during the last quarter. 83.49% of the stock is owned by institutional investors.

Several equities analysts have weighed in on the company. ValuEngine raised Aetna from a “hold” rating to a “buy” rating in a report on Tuesday, June 26th. Zacks Investment Research raised Aetna from a “sell” rating to a “hold” rating in a report on Monday, August 6th. Finally, Cantor Fitzgerald reaffirmed a “buy” rating and issued a $202.00 price objective on shares of Aetna in a report on Thursday, August 2nd. Seven analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. Aetna currently has an average rating of “Buy” and a consensus target price of $203.77.

Aetna stock opened at $203.41 on Thursday. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.44. Aetna has a 52 week low of $149.69 and a 52 week high of $206.66. The firm has a market cap of $66.41 billion, a PE ratio of 20.63, a price-to-earnings-growth ratio of 1.74 and a beta of 0.69.

Aetna (NYSE:AET) last posted its quarterly earnings results on Thursday, August 2nd. The company reported $3.43 EPS for the quarter, topping analysts’ consensus estimates of $3.04 by $0.39. Aetna had a return on equity of 20.66% and a net margin of 5.77%. The company had revenue of $15.56 billion during the quarter, compared to analysts’ expectations of $15.59 billion. During the same quarter in the previous year, the firm earned $3.42 EPS. Aetna’s revenue was up .2% on a year-over-year basis. As a group, research analysts forecast that Aetna will post 11.31 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Thursday, November 1st. Stockholders of record on Wednesday, October 24th will be issued a dividend of $0.50 per share. The ex-dividend date is Tuesday, October 23rd. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.98%. Aetna’s dividend payout ratio (DPR) is currently 20.28%.

About Aetna

Aetna Inc operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis.

Recommended Story: Closed-End Mutual Funds (CEFs)

Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply